Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiogenic shock

C E Rackley, R O Russell, J A Mantle

    Cardiovascular Clinics
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Cardiogenic shock, a severe complication of heart attack, leads to organ damage due to low blood pressure. Hemodynamic monitoring helps classify patients and guide treatment, but mortality remains high.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The clinical use of diuretics.

    Journal of the Medical Association of the State of Alabama·2010
    Same author

    ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

    Journal of the American College of Cardiology·2001
    Same author

    ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.

    Circulation·2001
    Same author

    ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.

    Circulation·2001
    Same author

    ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

    Journal of the American College of Cardiology·2001
    Same author

    ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).

    Journal of the American College of Cardiology·2001
    Same journal

    Echo-Doppler in valvular heart disease.

    Cardiovascular clinics·1993
    Same journal

    Arrhythmias in valvular heart disease.

    Cardiovascular clinics·1993
    Same journal

    The electrocardiogram in valvular heart disease.

    Cardiovascular clinics·1993
    Same journal

    Acute rheumatic fever.

    Cardiovascular clinics·1993
    Same journal

    Valvuloplasty.

    Cardiovascular clinics·1993
    Same journal

    Immediate postoperative management.

    Cardiovascular clinics·1993
    See all related articles

    Area of Science:

    • Cardiology
    • Critical Care Medicine
    • Cardiovascular Physiology

    Background:

    • Cardiogenic shock is a life-threatening complication of acute myocardial infarction.
    • It is characterized by reduced systemic blood pressure and impaired organ perfusion.
    • The underlying cause is extensive loss of myocardial contractility and left ventricular mechanical dysfunction.

    Purpose of the Study:

    • To identify distinct patient subgroups within cardiogenic shock using hemodynamic measurements.
    • To explore the role of hemodynamic monitoring in guiding pharmacologic management.
    • To outline a clinical scheme for optimizing cardiogenic shock treatment.

    Main Methods:

    • Hemodynamic measurements, including left ventricular filling pressure (pulmonary artery end-diastolic pressure) and cardiac index.

    Related Experiment Videos

  • Classification of patients into four subgroups based on hemodynamic profiles.
  • Assessment of treatment response to vasopressors, inotropes, and volume expansion.

    • Main Results:

    • Four distinct cardiogenic shock subgroups were identified with varying hospital mortality (13-100%).
    • Patients with normal left ventricular filling pressure may benefit from volume expansion.
    • Hemodynamic monitoring effectively guides the selection of pharmacologic agents.

    Conclusions:

    • Hemodynamic profiling is crucial for stratifying cardiogenic shock patients and tailoring therapy.
    • Optimal management involves a systematic approach using hemodynamic data to guide interventions.
    • Despite advances, high mortality persists, emphasizing the severity of myocardial damage.